slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 38,911-38,940
Pages 3,683
Rows per page 30
Component
38,911-38,940 of 110,471
22
AlTi | Investor Presentation Deck | 46 slidesAlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
23
The slide uses a two-column layout to contrast criteria for Wealth Management vs Asset Management acquisitions.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
28
AlTi | Investor Presentation Deck | 46 slidesAlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Financials2 hits
37
Details the SPAC merger with Cartesian Growth Corporation and partner lock-up provisions.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations 2 hits
39
The slide serves as a credibility-building page for the SPAC sponsor.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations 2 hits
03
Apollo Medical Holdings | Investor Presentation Deck | 45 slidesApollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations 2 hits
26
The slide uses a three-part structure: historical performance ranking, a comparative bar chart of savings, and a forward-looking opportunity statement.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Traction2 hits
28
The slide highlights both historical performance (25+ years) and current operational reach.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · Growth StrategyLoop · Quick Win Big Bet2 hits
05
The slide uses circular icons to represent studies and a horizontal timeline structure to indicate timing.argenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction2 hits
12
The central diagram is a circular flow/flywheel representation.argenx SE | Results Presentation Deck | 19 slides · argenx
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet2 hits
16
The 2x2 grid is used to present the four principles.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations 2 hits
21
The slide uses a three-column structure (Opportunity, Immediate focus, Outcome) to map strategic actions to results.Asos | Results Presentation Deck | 27 slides · Asos
Conference presentation Investor relations Beat · Solution2 hits
17
The slide uses a timeline diagram to illustrate the clinical trial flow and two boxes to detail study design and operational status.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
05
Uses a two-column layout to contrast 'Significant Burden' with 'Urgent Need for Innovation'.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
17
The slide uses a comparison structure to contrast safety/tolerability goals against efficacy goals.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
19
ATAI | Investor Presentation Deck | 41 slidesATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
21
The slide outlines the study arms, randomization ratios, and primary endpoint timing for two distinct clinical trials.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
28
The chart shows a non-inferiority test using the Hamilton Anxiety Rating Scale (Ham-A).ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
10
The table uses checkmarks to indicate the strength of effect for different GABA-A subtypes (alpha 1, 2, 3, 5).Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Solution2 hits
19
Includes a medical warning regarding photosensitivity.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 2 hits
20
The slide uses a comparison table to frame BAER-101's selectivity profile as a competitive advantage.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank 2 hits
29
Avenue Therapeutics | IPO Presentation Deck | 30 slidesAvenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Team2 hits
19
The slide contrasts the market problem (left) with the proposed solution/mechanism (right).BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 2 hits
22
The slide uses a process diagram to explain the experimental setup (biopsy -> organ culture -> measurement) followed by bar charts showing efficacy.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 2 hits
33
Uses a 2x2 matrix to represent the platform components.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 2 hits
38
The central circular diagram represents a feedback loop between lab capabilities and data integration.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 2 hits
45
The slide uses a causal chain framework to link PDE10 inhibition to therapeutic outcomes.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 2 hits
46
The slide uses a comparison table to contrast the drug's mechanism of action against competitors and highlights safety concerns with current standards of care.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 2 hits
52
The slide uses a flow-chart style to represent patient movement between treatment lines.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
54
Includes qualitative testimonials from psychiatrists to support the adoption thesis.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 2 hits